| Name |
Title |
Cancer Type |
Number of Genes with Data |
Number Observations |
Default Task |
| GDS1204 |
Lung cancer cell line response to motexafin gadolinium: time course |
Lung Cancer |
939 |
18 |
Classification |
| GDS1210 |
Gastric cancer |
Gastric Cancer |
548 |
30 |
Classification |
| GDS1263 |
Dukes B colon cancer recurrence |
Colon Cancer |
863 |
16 |
Classification |
| GDS1326 |
Breast cancer cells reexpressing estrogen receptor alpha response to 17beta-estradiol |
Breast Cancer |
939 |
12 |
Classification |
| GDS1390 |
Prostate cancer progression after androgen ablation |
Prostate Cancer |
939 |
20 |
Classification |
| GDS1424 |
Folic acid deficiency effect on colon cancer cells |
Colon Cancer |
708 |
22 |
Classification |
| GDS1439 |
Prostate cancer progression |
Prostate Cancer |
940 |
19 |
Classification |
| GDS1479 |
Carcinoma in situ lesions of the urinary bladder |
Bladder Cancer |
939 |
60 |
Classification |
| GDS1627 |
Breast cancer cell lines response to chemotherapeutic drugs: time course |
Breast Cancer |
877 |
83 |
Classification |
| GDS1688 |
Various lung cancer cell lines |
Lung Cancer |
939 |
29 |
Classification |
| GDS1732 |
Papillary thyroid cancer |
Thyroid Cancer |
940 |
14 |
Classification |
| GDS1746 |
Primary epithelial cell cultures from prostate tumors |
[] |
939 |
30 |
Classification |
| GDS1761 |
NCI60 cancer cell lines |
[] |
413 |
64 |
Classification |
| GDS1887 |
Rectal cancer cells and radiotherapy response |
Rectal Cancer |
813 |
46 |
Classification |
| GDS2250 |
Basal-like breast cancer tumors |
Breast Cancer |
940 |
47 |
Classification |
| GDS2297 |
Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133A) |
Lung Cancer |
939 |
45 |
Classification |
| GDS2298 |
Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133B) |
Lung Cancer |
279 |
18 |
Classification |
| GDS232 |
Medulloblastoma metastasis |
Medulloblastoma |
218 |
23 |
Classification |
| GDS2367 |
Tamoxifen effect on breast cancer cell line expressing estrogen receptor alpha and beta |
Breast Cancer |
939 |
17 |
Classification |
| GDS2384 |
Xenograft model of prostate carcinoma progression |
Prostate Cancer |
517 |
52 |
Classification |
| GDS2526 |
c-MYC depletion effect on carcinoma cell lines |
[] |
940 |
18 |
Classification |
| GDS2545 |
Metastatic prostate cancer (HG-U95A) |
Prostate Cancer |
813 |
171 |
Classification |
| GDS2546 |
Metastatic prostate cancer (HG-U95B) |
Prostate Cancer |
263 |
167 |
Classification |
| GDS2547 |
Metastatic prostate cancer (HG-U95C) |
Prostate Cancer |
216 |
164 |
Classification |
| GDS2609 |
Early onset colorectal cancer: normal-appearing colonic mucosa |
Colorectal Cancer |
940 |
22 |
Classification |
| GDS2626 |
Epidermal growth factor and heregulin effect on breast cancer cell line: dose response and time course |
Breast Cancer |
939 |
57 |
Classification |
| GDS2770 |
Estrogen effect on breast cancer cell line coexpressing estrogen receptors alpha and beta |
Breast Cancer |
939 |
12 |
Classification |
| GDS2771 |
Large airway epithelial cells from cigarette smokers with suspect lung cancer |
Lung Cancer |
939 |
192 |
Classification |
| GDS2785 |
Ovarian cancer tumors after neo-adjuvant chemotherapy |
Ovarian Cancer |
813 |
43 |
Classification |
| GDS2918 |
Colorectal cancer markers in plasma |
Colorectal Cancer |
371 |
20 |
Classification |
| GDS2971 |
Hemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line |
Prostate Cancer |
893 |
12 |
Classification |
| GDS3017 |
Cervical cancer response to chemoradiotherapy |
Cervical Cancer |
884 |
156 |
Classification |
| GDS3096 |
Inflammatory breast cancer: stroma |
Breast Cancer |
939 |
47 |
Classification |
| GDS3097 |
Inflammatory breast cancer: tumor |
Breast Cancer |
939 |
48 |
Classification |
| GDS3116 |
Letrozole effect on breast cancer tumors |
Breast Cancer |
939 |
116 |
Classification |
| GDS3139 |
Breast cancer: histologically normal breast epithelium |
Breast Cancer |
939 |
29 |
Classification |
| GDS3179 |
Lung metastatic breast cancer cell line response to metadherin depletion |
Breast Cancer |
949 |
12 |
Classification |
| GDS3217 |
Estradiol effect on breast cancer cell line expressing estrogen receptor: time course |
Breast Cancer |
940 |
18 |
Classification |
| GDS3233 |
Cervical cancer tumorigenesis |
Cervical Cancer |
939 |
61 |
Classification |
| GDS3289 |
Prostate cancer progression at the cellular level |
Prostate Cancer |
709 |
104 |
Classification |
| GDS3324 |
Stromal cells and invasive breast cancer development |
Breast Cancer |
939 |
66 |
Classification |
| GDS3388 |
Bisphenol A effect on nonmalignant breast epithelial cell aspirates from breast cancer patients |
Breast Cancer |
940 |
24 |
Classification |
| GDS3482 |
X-linked inhibitor of apoptosis XIAP depletion effect on a colorectal cancer cell line |
Colorectal Cancer |
940 |
18 |
Classification |
| GDS3501 |
Synchronous and metachronous liver metastases from colorectal cancer |
Colorectal Cancer |
940 |
18 |
Classification |
| GDS3592 |
Ovarian normal surface epithelia and ovarian cancer epithelial cells |
Ovarian Cancer |
940 |
24 |
Classification |
| GDS360 |
Breast cancer and docetaxel treatment |
Breast Cancer |
813 |
24 |
Classification |
| GDS3603 |
Renal cancer response to rapamycin analog CCI-779 treatment: time course |
renal cancer |
813 |
79 |
Classification |
| GDS3627 |
Non-small lung cancer subtypes: adenocarcinoma and squamous cell carcinoma |
Lung Cancer |
940 |
58 |
Classification |
| GDS3638 |
Actein effect on breast cancer cell line: dose response and time course |
Breast Cancer |
939 |
16 |
Classification |
| GDS3716 |
Breast cancer: histologically normal breast epithelium |
Breast Cancer |
939 |
42 |
Classification |
| GDS3721 |
Pretreatment breast needle biopsies of locally advanced breast cancer |
Breast Cancer |
940 |
28 |
Classification |
| GDS3756 |
Preoperative radio-chemotherapy effect on rectal cancer |
Rectal Cancer |
921 |
42 |
Classification |
| GDS3792 |
Carboplatin effect on epithelial ovarian cancer cell line: time course |
Ovarian Cancer |
940 |
12 |
Classification |
| GDS3836 |
Multistep pancreatic carcinogenesis: epithelial cells |
[] |
940 |
22 |
Classification |
| GDS3837 |
Non-small cell lung carcinoma in female nonsmokers |
[] |
940 |
120 |
Classification |
| GDS3861 |
Synthetic androgen R1881 effect on transcription factor SRF-deficient prostate cancer cells |
Prostate Cancer |
940 |
12 |
Classification |
| GDS3872 |
Xenograft ovarian tumor response to anti-cancer therapeutic MT19: time course |
[] |
928 |
15 |
Classification |
| GDS3945 |
Renal clear cell carcinoma-thyroid hormone receptor mutants: HepG3 cell line |
'Hepatocellular carcinoma' |
928 |
42 |
Classification |
| GDS3952 |
Breast cancer patients: peripheral blood mononuclear cells |
Breast Cancer |
940 |
162 |
Classification |
| GDS3966 |
Melanoma metastasis |
Melanoma |
939 |
83 |
Classification |
| GDS4051 |
Tamoxifen-resistant breast cancer cell line MCF7 subclones |
Breast Cancer |
940 |
24 |
Classification |
| GDS4053 |
Postmenopausal estrogen receptor α-positive breast tumor with PIK3CA mutation |
[] |
940 |
43 |
Classification |
| GDS4056 |
ER-positive/HER2-negative and ER-negative/HER2-negative breast cancer biopsies (USO-02103 cohort) |
Breast Cancer |
939 |
61 |
Classification |
| GDS4057 |
ER-positive/HER2-negative and ER-negative/HER2-negative breast cancer biopsies (MDACC/IGR cohort) |
Breast Cancer |
939 |
103 |
Classification |
| GDS4063 |
Estrogen or insulin-like growth factor I stimulated MCF-7 breast cancer cells: time course |
Breast Cancer |
939 |
17 |
Classification |
| GDS4066 |
Ovarian cancer intraperitoneal xenograft model |
Ovarian Cancer |
940 |
15 |
Classification |
| GDS4088 |
Variable breast cancer tumor sample collection methods |
Breast Cancer |
939 |
86 |
Classification |
| GDS4090 |
Proteasome inhibitor Bortezomib or proteasome subunit knockdown effect on MCF7 breast cancer cells |
Breast Cancer |
957 |
21 |
Classification |
| GDS4092 |
Breast cancer cell lines treated with methylated or unmethylated DNA oligos |
Breast Cancer |
940 |
12 |
Classification |
| GDS4093 |
Anastrozole/Fulvestrant/Gefitinib neoadjuvant therapy of estrogen receptor positive breast cancer patients: tumor core biopsies |
Breast Cancer |
940 |
22 |
Classification |
| GDS4095 |
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2 |
Breast Cancer |
940 |
14 |
Classification |
| GDS4100 |
Saliva of pre-treatment pancreatic cancer patients |
Pancreatic Cancer |
940 |
24 |
Classification |
| GDS4109 |
Recurrent and non-recurrent prostate cancer primary tumors |
Prostate Cancer |
939 |
79 |
Classification |
| GDS4114 |
Reactive stroma of breast and prostate cancer |
Prostate Cancer |
940 |
24 |
Classification |
| GDS4158 |
LNCap prostate cancer cell line response to loss of COnstitutive Photomorphogenic-1 and ETV1 |
Prostate Cancer |
940 |
16 |
Classification |
| GDS4198 |
Australian patient cohort: gastric adenocarcinoma |
Gastric Cancer |
940 |
70 |
Classification |
| GDS4345 |
Quadriceps muscle from cancer patients before and after surgery: sequential biopsies |
Gastrointestinal Cancer |
940 |
30 |
Classification |
| GDS4381 |
Patient-derived colorectal cancer explants |
Colorectal Cancer |
940 |
64 |
Classification |
| GDS4382 |
Colorectal cancer tumors |
Colorectal Cancer |
940 |
34 |
Classification |
| GDS4386 |
Ls174T colon cancer cell line response to Wnt signaling inhibition |
Colon Cancer |
940 |
12 |
Classification |
| GDS4393 |
Unresectable colorectal cancer primary or metastatic lesions: training set |
Colorectal Cancer |
940 |
54 |
Classification |
| GDS4395 |
External beam radiation therapy effect on prostate cancer patients: peripheral white blood cells |
Prostate Cancer |
940 |
80 |
Classification |
| GDS4396 |
Unresectable colorectal cancer primary or metastatic lesions: test set |
Colorectal Cancer |
940 |
29 |
Classification |
| GDS4454 |
Fibroblast growth factor receptor 3 depletion effect on bladder cancer cell line RT112 |
Bladder Cancer |
940 |
24 |
Classification |
| GDS4456 |
High-risk bladder cancer |
Bladder Cancer |
940 |
93 |
Classification |
| GDS4487 |
Ras/MEK inhibition effect on IFN-alpha treated cancer cell line: time course |
[] |
928 |
30 |
Classification |
| GDS4513 |
Clinical outcome of stage UICC II colon cancer patients |
Colon Cancer |
940 |
53 |
Classification |
| GDS4515 |
Microsatellite-unstable colorectal cancer |
Colorectal Cancer |
939 |
49 |
Classification |
| GDS4516 |
Colorectal cancer: laser microdissected tumor tissues |
Colorectal Cancer |
940 |
104 |
Classification |
| GDS4589 |
Stage I endometrial cancer: microdissected frozen uterine tumors |
Endometrial Cancer |
940 |
103 |
Classification |
| GDS4664 |
Lymph node-positive, early stage cervical cancer |
Cervical Cancer |
940 |
39 |
Classification |
| GDS470 |
Cervical cancer |
Cervical Cancer |
352 |
32 |
Classification |
| GDS4718 |
Colorectal cancer: homogenized tumor tissues |
Colorectal Cancer |
940 |
44 |
Classification |
| GDS4761 |
Breast cancer metastases from different anatomical sites: fine-needle aspiration biopsies |
Breast Cancer |
943 |
91 |
Classification |
| GDS4762 |
Fibroblast response to coculture with basal breast cancer cells |
Breast Cancer |
928 |
80 |
Classification |
| GDS4764 |
Dual specificity phosphatase-4 loss effect on basal-like breast cancer cell lines |
Breast Cancer |
922 |
36 |
Classification |
| GDS4766 |
Pregnancy-associated breast cancer: laser capture microdissected epithelia and stroma |
Breast Cancer |
940 |
33 |
Classification |
| GDS4794 |
Small cell lung cancers |
Lung Cancer |
940 |
65 |
Classification |
| GDS4814 |
Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab |
Ovarian Cancer |
948 |
23 |
Classification |
| GDS4824 |
Prostate cancer |
Prostate Cancer |
940 |
21 |
Classification |
| GDS4853 |
Stem cell factor SOX2-deficient stomach carcinoma cell line: time course |
Gastric Cancer |
928 |
20 |
Classification |
| GDS4882 |
Hepatocellular carcinoma: peripheral blood mononuclear cells |
'Hepatocellular carcinoma' |
940 |
26 |
Classification |
| GDS4950 |
High-grade serous ovarian cancer resistant to platinum-based chemotherapy |
Ovarian Cancer |
940 |
28 |
Classification |
| GDS4952 |
BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response |
Prostate Cancer |
940 |
24 |
Classification |
| GDS4957 |
FOXA1 overexpression effect on prostate cancer cell line |
Prostate Cancer |
948 |
12 |
Classification |
| GDS4964 |
Telomere-elongated, prostate cancer cells |
Prostate Cancer |
940 |
16 |
Classification |
| GDS5023 |
Fibroblast growth factor receptor inhibition effect on malignant urothelial cells deficient in TGFβ-activated kinase 1 |
Bladder Cancer |
928 |
12 |
Classification |
| GDS5027 |
NeOAdjuvant Herceptin (NOAH) trial: formalin-fixed, paraffin-embedded breast cancer biopsies |
Breast Cancer |
940 |
156 |
Classification |
| GDS5232 |
Early and late onset colorectal cancers |
Colorectal Cancer |
921 |
50 |
Classification |
| GDS5267 |
Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course |
Prostate Cancer |
940 |
45 |
Classification |
| GDS5268 |
Cyclin-dependent kinase inhibitor R547 effect on colon cancer cell line: dose response and time course |
Colon Cancer |
940 |
74 |
Classification |
| GDS5287 |
SMRT depleted breast cancer cell line response to estradiol: time course |
Breast Cancer |
928 |
24 |
Classification |
| GDS534 |
Smoking-induced changes in airway transcriptome |
[] |
939 |
75 |
Classification |
| GDS535 |
Prostate cancer antiandrogen resistance |
Prostate Cancer |
813 |
14 |
Classification |
| GDS5621 |
Estradiol effect on MCF7 breast cancer cells expressing progesterone receptor-B |
Breast Cancer |
948 |
12 |
Classification |
| GDS5800 |
Interstitial fluid flow effect on noninvasive and invasive ERBB2-positive breast cancer cells |
Breast Cancer |
948 |
12 |
Classification |
| GDS5801 |
Protein kinase C δ deficiency effect on breast cancer cells |
Breast Cancer |
948 |
12 |
Classification |
| GDS6100 |
MicroRNA-135b overexpression effect on prostate cancer cell line: time course |
Prostate Cancer |
948 |
12 |
Classification |
| GDS806 |
Estrogen positive breast cancer recurrence during tamoxifen therapy: whole tissue tumor |
Breast Cancer |
827 |
60 |
Classification |
| GDS807 |
Estrogen positive breast cancer recurrence during tamoxifen therapy: microdissected tumor |
Breast Cancer |
827 |
60 |
Classification |
| GDS845 |
Breast cancer cell line ME16C response to chemotherapeutics: time course |
Breast Cancer |
877 |
18 |
Classification |
| GDS846 |
Breast cancer cell line HME-CC response to chemotherapeutics: time course |
Breast Cancer |
877 |
19 |
Classification |
| GDS847 |
Breast cancer cell line MCF-7 response to chemotherapeutics: time course |
Breast Cancer |
877 |
19 |
Classification |
| GDS848 |
Breast cancer cell line ZR-75-1 response to chemotherapeutics: time course |
Breast Cancer |
877 |
19 |
Classification |
| GDS901 |
Estrogen receptor alpha L540Q mutation effect on gene induction by estradiol: time course |
Breast Cancer |
939 |
12 |
Classification |
| GSE100480 |
Consensus Molecular Subtypes of colorectal cancer are recapitulated in in vitro and in vivo models [patient tumors and PDX models] |
Colorectal Cancer |
978 |
55 |
Classification |
| GSE100549 |
Consensus Molecular Subtypes of colorectal cancer are recapitulated in in vitro and in vivo models [primary cell lines AMC/Palermo] |
Colorectal Cancer |
978 |
15 |
Classification |
| GSE100550 |
Consensus Molecular Subtypes of colorectal cancer are recapitulated in in vitro and in vivo models |
Colorectal Cancer |
978 |
106 |
Classification |
| GSE10089 |
Anti-tumor Activity of Histone Deacetylase Inhibitors in Non-Small Cell Lung Cancer Cells |
Lung Cancer |
978 |
23 |
Classification |
| GSE101896 |
Transcriptome analysis by expression microarrays of colorectal cancer derived from the Cancer Institute Hospital of Japanese Foundation for Cancer Research. |
Colorectal Cancer |
978 |
90 |
Classification |
| GSE101929 |
Gene expression data from African Americans and European Americans with non-small cell lung cancer |
Lung Cancer |
978 |
66 |
Classification |
| GSE10245 |
Gene expression differences between adenocarcinoma and squamous cell carcinoma in human NSCLC |
Lung Cancer |
978 |
58 |
Classification |
| GSE102484 |
Expression data from invasive breast cancer patient |
Breast Cancer |
978 |
683 |
Classification |
| GSE10270 |
Bisphenol A induces a profile of tumor aggressiveness in high-risk cells of breast cancer patients |
Breast Cancer |
978 |
24 |
Classification |
| GSE102907 |
Transcriptome analysis by expression microarrays of breast cancer derived from the Cancer Institute Hospital of Japanese Foundation for Cancer Research. |
Breast Cancer |
978 |
61 |
Classification |
| GSE103091 |
Gene-expression molecular subtyping of triple-negative breast cancer tumors |
Breast Cancer |
978 |
238 |
Classification |
| GSE103340 |
Patient-derived xenograft model identifies clinically relevant subtype-specific features of colorectal cancer |
Colorectal Cancer |
978 |
71 |
Classification |
| GSE103512 |
Gene expression profiles of breast, colorectal, prostate, and non-small cell lung cancer |
Non-Small Cell Lung Cancer |
978 |
280 |
Classification |
| GSE103668 |
Pre-treatment expression data from neoadjuvant platinum & bevacizumab treated triple negative breast cancer patients |
Breast Cancer |
978 |
21 |
Classification |
| GSE103865 |
Expression data from human breast cancer tissue |
Breast Cancer |
978 |
14 |
Classification |
| GSE103888 |
Transcriptomic study of bronchoalveolar lavage cells in the local environment of non-small cell lung cancer |
Non-Small Cell Lung Cancer |
978 |
19 |
Classification |
| GSE104419 |
Examining alterations in gene expression of prostate cancer cells in presence or absence of PSMA |
Prostate Cancer |
978 |
12 |
Classification |
| GSE105437 |
Expression data from endothelial cell |
[] |
978 |
22 |
Classification |
| GSE106191 |
Transcriptome analysis by expression microarrays of endometrial cancer derived from the Cancer Institute Hospital of Japanese Foundation for Cancer Research. |
Endometrial Cancer |
978 |
97 |
Classification |
| GSE10797 |
Transcriptomes of breast epithelium and stroma in normal reduction mammoplasty and invasive breast cancer patients. |
Breast Cancer |
978 |
66 |
Classification |
| GSE10810 |
Gene expression signatures in breast cancer distinguish phenotype charact., histological subtypes, and tumor invasivness |
Breast Cancer |
890 |
58 |
Classification |
| GSE108345 |
mRNA expression from three human gastric cancer cell lines (MKN1, NUGC4 and AZ521) following either 10ug/ml Pam3Cys-Ser-(Lys)4 and FSL-1 or no treatment. |
Gastric Cancer |
929 |
18 |
Classification |
| GSE10961 |
Gene expression profiling of liver metastases from colorectal cancer |
Colorectal Cancer |
978 |
18 |
Classification |
| GSE11001 |
Genome-wide expression profiling from formalin-fixed paraffin-embedded breast cancer core biopsies |
Breast Cancer |
978 |
30 |
Classification |
| GSE110223 |
Expression data from 13 patients with colorectal cancer |
Colorectal Cancer |
978 |
26 |
Classification |
| GSE110224 |
Expression data from 17 patients with colorectal cancer |
Colorectal Cancer |
978 |
34 |
Classification |
| GSE11121 |
The humoral immune system has a key prognostic impact in node-negative breast cancer |
Breast Cancer |
978 |
200 |
Classification |
| GSE112790 |
Comprehensive molecular characterization of liver cancer and inheritance of the phenotypic traits during tumor recurrence [tissue] |
Liver Cancer |
978 |
198 |
Classification |
| GSE11352 |
Timecourse of estradiol (10nM) exposure in MCF7 breast cancer cells. |
Breast Cancer |
978 |
18 |
Classification |
| GSE114168 |
Medullary breast carcinoma, a triple-negative breast cancer subtype associated with BCLG overexpression. |
Breast Cancer |
978 |
53 |
Classification |
| GSE114761 |
Transforming Growth Factor β-Induced Epithelial-to-Mesenchymal Signature Predicts Metastasis-Free Survival in Non-Small Cell Lung Cancer. |
Lung Cancer |
978 |
42 |
Classification |
| GSE115810 |
Expression profiling of endometrial cancer of different grades |
Endometrial Cancer |
978 |
27 |
Classification |
| GSE119409 |
Expression data from rectal cancer |
Rectal Cancer |
978 |
66 |
Classification |
| GSE122306 |
ETV5 silencing in bladder cancer cell line 97-7 |
Bladder Cancer |
978 |
12 |
Classification |
| GSE12276 |
Expression data from primary breast tumors |
Breast Cancer |
978 |
204 |
Classification |
| GSE124069 |
BRD4 inhibitor JQ1 increase the sensitivity of arsenic trioxide in pancreatic cancer |
Lung Cancer |
978 |
30 |
Classification |
| GSE124647 |
SET ER/PR - A robust 18-gene Predictor for Sensitivity to Endocrine Therapy for Metastatic Breast Cancer |
Breast Cancer |
978 |
140 |
Classification |
| GSE125915 |
Expression analysis of cancer of unknown primary (CUP) |
[] |
978 |
134 |
Classification |
| GSE125989 |
Prinary breast cancers and brain metastasis |
Breast Cancer |
978 |
32 |
Classification |
| GSE127760 |
Breast cancer cell line panel stimulated with estradiol |
Breast Cancer |
978 |
36 |
Classification |
| GSE12777 |
Gene expression profiling of 51 human breast cancer cell lines |
Breast Cancer |
978 |
51 |
Classification |
| GSE12790 |
Gene expression profiling of human breast cancers and cancer cell lines |
Breast Cancer |
978 |
98 |
Classification |
| GSE12791 |
Paclitaxel resistant MDA-MB-231 Cells and resensitization with bexarotene treatment |
Breast Cancer |
978 |
16 |
Classification |
| GSE12945 |
Expression data from colorectal cancers |
Breast Cancer |
978 |
62 |
Classification |
| GSE129551 |
Discovery cohort for SET ER/PR |
Breast Cancer |
978 |
147 |
Classification |
| GSE129560 |
Study to compare SET ER/PR index values from Affymetrix U133A microarrays to values from targeted RNASeq and to validate technical reproducibility on U133A microarrays |
[] |
978 |
128 |
Classification |
| GSE130402 |
MiRNA-mediated induction of mesenchymal-to-epithelial transition (MET) between cancer cell types is significantly modulated by inter-cellular molecular variability |
Ovarian Cancer |
978 |
45 |
Classification |
| GSE131027 |
High frequency of pathogenic germline variants in genes associated with homologous recombination repair in patients with advanced solid cancers |
Cervical Cancer |
978 |
92 |
Classification |
| GSE13309 |
Tobacco Smoke Induces Polycomb-mediated Repression of Dickkopf-1 in Lung Cancer Cells |
Lung Cancer |
978 |
24 |
Classification |
| GSE13525 |
Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer |
Ovarian Cancer |
978 |
12 |
Classification |
| GSE13548 |
Expression data from human cancer cells treated with UPR modulators under ER stress conditions |
[] |
978 |
42 |
Classification |
| GSE135565 |
Gene expression profiles of the standardized uptake value in 18F-fluorodeoxyglucose positron emission tomography in tripple negative breast cancer |
Breast Cancer |
978 |
84 |
Classification |
| GSE13787 |
Frequent PTEN genomic alterations and activated PI3K pathway in basal-like breast cancer |
Breast Cancer |
976 |
23 |
Classification |
| GSE14017 |
Metastases of breast cancer (U133plus2) |
Breast Cancer |
978 |
29 |
Classification |
| GSE14018 |
Metastases of breast cancer (U133A) |
Breast Cancer |
978 |
36 |
Classification |
| GSE140494 |
Gene expression-based prediction of neodjuvant chemotherapy response in early breast cancer |
Breast Cancer |
978 |
91 |
Classification |
| GSE14245 |
Multiple Salivary Biomarkers for Early Detection of Pancreatic Cancer |
Pancreatic Cancer |
978 |
24 |
Classification |
| GSE143985 |
Clinical significance of gene signature generated from the grade of tumor budding in colorectal cancer |
Colorectal Cancer |
978 |
91 |
Classification |
| GSE14407 |
Ovarian Cancer gene expression profiling identifies the surface of the ovary as a stem cell niche |
Ovarian Cancer |
978 |
24 |
Classification |
| GSE146558 |
Gene Expression Signature of Microcalcification among Taiwanese Breast Cancer |
Breast Cancer |
978 |
109 |
Classification |
| GSE14764 |
A Prognostic Gene Expression Index in Ovarian Cancer |
Ovarian Cancer |
978 |
80 |
Classification |
| GSE14814 |
Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer |
Lung Cancer |
978 |
133 |
Classification |
| GSE14986 |
Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common clonal drug-resistant progenitor |
Breast Cancer |
978 |
30 |
Classification |
| GSE14990 |
MYC regulation of a "poor prognosis" metastatic cancer cell state |
Metastatic Cancer |
978 |
15 |
Classification |
| GSE15026 |
Expression data from breast cancer cell lines with various colony-forming ability |
Breast Cancer |
978 |
30 |
Classification |
| GSE153796 |
Gene expression data from breast ductal cells from women at normal risk or high risk for breast cancer |
Breast Cancer |
978 |
29 |
Classification |
| GSE15548 |
SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells |
Breast Cancer |
978 |
29 |
Classification |
| GSE15578 |
Expression Data from Ovarian Surface Kinome |
Ovarian Cancer |
978 |
17 |
Classification |
| GSE15641 |
Gene signatures of progression and metastasis in renal cell cancer |
Renal Cell Cancer |
978 |
92 |
Classification |
| GSE157009 |
Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (Alliance) [cohort I] |
Lung Cancer |
978 |
249 |
Classification |
| GSE157010 |
Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (Alliance) [Cohort II] |
Lung Cancer |
978 |
235 |
Classification |
| GSE157011 |
Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (Alliance) |
Lung Cancer |
978 |
484 |
Classification |
| GSE158309 |
Prognostic significance of interferon-γ and its signaling pathway in early breast cancer depends on the molecular subtypes |
Breast Cancer |
978 |
461 |
Classification |
| GSE15852 |
Expression data from human breast tumors and their paired normal tissues |
Breast Cancer |
978 |
86 |
Classification |
| GSE15932 |
Blood biomarkers of pancreatic cancer associated diabetes identified by peripheral blood-based gene expression profiles |
Pancreatic Cancer |
978 |
32 |
Classification |
| GSE15960 |
Expression data from human colonic epithelial cells normal (N), adenoma (AD) or colorectal cancer (CRC) tissues |
Colorectal Cancer |
978 |
18 |
Classification |
| GSE161158 |
A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer |
Colorectal Cancer |
978 |
250 |
Classification |
| GSE16157 |
Mitochondria regulate the unfolded protein response leading to cancer cell survival under glucose deprivation conditions |
[] |
978 |
38 |
Classification |
| GSE16391 |
GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
Breast Cancer |
978 |
55 |
Classification |
| GSE163950 |
Transcriptome profiles associated with selenium deficiency dependent oxidative stress identify potential diagnostic and therapeutic targets in liver cancer cells |
Liver Cancer |
606 |
24 |
Classification |
| GSE164191 |
Blood based expression of colorectal cancer and healthy controls |
Colorectal Cancer |
978 |
121 |
Classification |
| GSE16648 |
Networking of differentially expressed genes in human cancer cell lines resistant to methotrexate |
[] |
978 |
42 |
Classification |
| GSE16795 |
Affymetrix HG-U133A gene expression profiles of 39 human breast cancer cell lines |
Breast Cancer |
978 |
39 |
Classification |
| GSE16873 |
Early Dysregulation of Cell Adhesion and Extracellular Matrix Pathways in Breast Cancer Progression |
Breast Cancer |
978 |
40 |
Classification |
| GSE17025 |
Gene Expression Analysis of Stage I Endometrial Cancers |
Endometrial Cancer |
978 |
103 |
Classification |
| GSE17347 |
Expression data of two human cancer cell lines cultivated in 2-dimensional (2D) vs. 3-dimensional (3D) cell culture |
[] |
978 |
12 |
Classification |
| GSE17356 |
Expression data from prostate cancer epithelial cells from African American and European American men |
Prostate Cancer |
926 |
27 |
Classification |
| GSE17482 |
Gene expression profiles regulated by Stat5a/b vs. Stat3 in human prostate cancer cells. |
Prostate Cancer |
978 |
18 |
Classification |
| GSE17536 |
Metastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (Moffitt Samples) |
Colorectal Cancer |
978 |
177 |
Classification |
| GSE17537 |
Metastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (VMC Samples) |
Colorectal Cancer |
978 |
55 |
Classification |
| GSE17906 |
Gene expression down-regulation in prostate tumor-associated stromal cells involves organ-specific genes |
Prostate Cancer |
978 |
25 |
Classification |
| GSE17951 |
Gene expression analysis of prostate cancer samples using Affymetrix U133Plus2 array |
Prostate Cancer |
978 |
154 |
Classification |
| GSE18088 |
Correlation of molecular profiles and clinical outcome of stage UICC II colon cancer patients |
Colon Cancer |
978 |
53 |
Classification |
| GSE18105 |
Stage II and stage III colorectal cancer |
Colorectal Cancer |
978 |
111 |
Classification |
| GSE18521 |
A gene signature predictive for outcome in advanced ovarian cancer identifies a novel survival factor: MAGP2 |
Ovarian Cancer |
978 |
75 |
Classification |
| GSE18560 |
Deciphering the Wnt-dependent gene signature in colorectal cancer cells |
Colorectal Cancer |
978 |
12 |
Classification |
| GSE18670 |
Pancreatic cancer circulating tumor cells express a cell motility gene signature that predicts survival after surgery |
Pancreatic Cancer |
452 |
24 |
Classification |
| GSE18842 |
Gene expression analysis of human lung cancer and control samples |
Lung Cancer |
978 |
91 |
Classification |
| GSE18864 |
Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
Breast Cancer |
978 |
84 |
Classification |
| GSE19027 |
Antioxidant response gene expression in the bronchial airway epithelial cells of smokers at risk for lung cancer |
Lung Cancer |
978 |
60 |
Classification |
| GSE19352 |
Activation of phosphatidylcholine-cycle enzymes in human epithelial ovarian cancer cells |
Ovarian Cancer |
978 |
28 |
Classification |
| GSE19639 |
Hyperactivation of PI3K promotes escape from hormone dependence in estrogen receptor-positive breast cancer |
Breast Cancer |
978 |
24 |
Classification |
| GSE19650 |
Expression data from epithelial cells during the process of multistep pancreatic carcinogenesis |
Pancreatic Cancer |
978 |
22 |
Classification |
| GSE19697 |
An expression profile that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy |
Breast Cancer |
978 |
24 |
Classification |
| GSE19713 |
Expression data of 3 prostate cancer stem cell primary lines comparing spheres and parental/adherent culture |
Prostate Cancer |
978 |
12 |
Classification |
| GSE19722 |
Airway Basal Cells of Healthy Smokers Express an Embryonic Stem Cell Signature Relevant to Lung Cancer |
[] |
978 |
64 |
Classification |
| GSE19804 |
Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan |
Lung Cancer |
978 |
120 |
Classification |
| GSE19826 |
Expression data from gastric cancer |
Gastric Cancer |
978 |
27 |
Classification |
| GSE20194 |
MAQC-II Project: human breast cancer (BR) data set |
Breast Cancer |
978 |
278 |
Classification |
| GSE20266 |
Salivary Transcriptomic and Proteomic Biomarkers for Breast Cancer Detection |
Breast Cancer |
978 |
20 |
Classification |
| GSE20271 |
Expression data from breast cancer FNA biopsies from patients |
Breast Cancer |
978 |
178 |
Classification |
| GSE2034 |
Breast cancer relapse free survival |
Breast Cancer |
978 |
286 |
Classification |
| GSE20437 |
Histologically normal epithelium from breast cancer patients and cancer-free prophylactic mastectomy patients |
Breast Cancer |
978 |
42 |
Classification |
| GSE20685 |
Microarray-based molecular subtyping of breast cancer |
Breast Cancer |
978 |
327 |
Classification |
| GSE20854 |
EGFR Isoforms and Gene Regulation in Human Endometrial Cancer Cells |
Endometrial Cancer |
978 |
24 |
Classification |
| GSE21293 |
Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer |
Esophageal Cancer |
978 |
35 |
Classification |
| GSE21510 |
Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer |
Colorectal Cancer |
978 |
148 |
Classification |
| GSE21653 |
A gene expression signature identifies two prognostic subgroups of basal breast cancer |
Breast Cancer |
978 |
266 |
Classification |
| GSE21947 |
Gene expression profiles of breast cancer subtypes are detectable in histologically normal breast epithelium |
Breast Cancer |
978 |
30 |
Classification |
| GSE22035 |
Gene expression data in estrogen receptor alpha positive breast tumors with and without PIK3CA mutations. |
Breast Cancer |
978 |
43 |
Classification |
| GSE22093 |
Expression data from breast cancer FNA biopsies from patients |
Breast Cancer |
978 |
103 |
Classification |
| GSE22250 |
Epigenetic portraits of human breast cancers (various cell lines expression data) |
Breast Cancer |
978 |
18 |
Classification |
| GSE22513 |
Markers of Taxane Sensitivity in Breast Cancer |
Breast Cancer |
978 |
28 |
Classification |
| GSE22533 |
Breast cancer cells resistant to hormone deprivation maintain an estrogen receptor alpha-dependent, E2F-directed transcriptional program |
Breast Cancer |
978 |
12 |
Classification |
| GSE22593 |
WT and DBDmut Breast Cancer Cells |
Breast Cancer |
978 |
24 |
Classification |
| GSE22597 |
Expression data from Fine Needle Aspiration (FNA) biopsies from breast cancer patients |
Breast Cancer |
978 |
82 |
Classification |
| GSE22598 |
Clinical significance of UNC5B Expression in Colorectal Cancer |
Colorectal Cancer |
978 |
38 |
Classification |
| GSE22600 |
Tissue Specific Pathways for Estrogen Regulation of Ovarian Cancer Growth and Metastasis |
Breast Cancer |
978 |
15 |
Classification |
| GSE22606 |
Identification of an SRF- and androgen-dependent gene signature in prostate cancer |
Prostate Cancer |
978 |
12 |
Classification |
| GSE22865 |
CHAC1 mRNA expression is a strong prognostic biomarker in breast and ovarian cancer |
Breast Cancer |
978 |
12 |
Classification |
| GSE22973 |
An Invasive Gene Expression Signature in Pancreas Cancer. |
Pancreatic Cancer |
978 |
12 |
Classification |
| GSE23177 |
Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs. |
Breast Cancer |
898 |
116 |
Classification |
| GSE23553 |
Gene expression changes with induction of in-vitro platinum-resistance in ovarian cancer cell lines. |
Ovarian Cancer |
978 |
56 |
Classification |
| GSE23554 |
Ovarian Cancer Dataset |
Brain Cancer |
978 |
28 |
Classification |
| GSE23593 |
Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome |
Breast Cancer |
978 |
50 |
Classification |
| GSE23640 |
Gene-expression profile of breast cancer cell lines and sorted breast cancer epithelial cells |
Breast Cancer |
978 |
14 |
Classification |
| GSE23878 |
Genome Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy |
Colorectal Cancer |
978 |
59 |
Classification |
| GSE23926 |
Gene expression profiles in human kidney cancer cells in response to FoxO1 or FoxO3 activation |
Kidney Cancer |
978 |
12 |
Classification |
| GSE23988 |
Expression data from breast cancer FNA biopsies from patients (US samples) |
Breast Cancer |
978 |
61 |
Classification |
| GSE24185 |
Gene transcription signature of obesity in breast cancer |
Breast Cancer |
978 |
103 |
Classification |
| GSE2443 |
Prostate cancer - comparison of androgen-dependent and -independent microdissected primary tumor |
Prostate Cancer |
978 |
20 |
Classification |
| GSE24468 |
Elucidation of the Mechanisms by which the Progesterone Receptor Inhibits Inflammatory Responses in Cellular Models of Breast Cancer |
Breast Cancer |
978 |
20 |
Classification |
| GSE24514 |
Expression data from human MSI colorectal cancer and normal colonic mucosa |
Colorectal Cancer |
978 |
49 |
Classification |
| GSE24717 |
Using a Stem Cell-Based Signature to Guide Therapeutic Selection in Cancer |
Breast Cancer |
978 |
22 |
Classification |
| GSE24795 |
Gene Expression differences between replication error deficient and proficient colorectal cancers: the dominant role of deletions in 3’UTR poly T sequences |
Colorectal Cancer |
978 |
30 |
Classification |
| GSE25011 |
Study for evaluating the effect of cold ischemic time and RNA stabilization method on RNA integrity and gene expression measurements |
Breast Cancer |
978 |
86 |
Classification |
| GSE25055 |
Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
Breast Cancer |
978 |
310 |
Classification |
| GSE25065 |
Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
Breast Cancer |
978 |
198 |
Classification |
| GSE25066 |
Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
Breast Cancer |
978 |
508 |
Classification |
| GSE25136 |
Optimizing molecular signatures for prostate cancer recurrence |
Prostate Cancer |
978 |
79 |
Classification |
| GSE25428 |
Gene expression profiles of ovarian cancer cell lines in the presence and absence of a DNA methyltransferase inhibitor |
Ovarian Cancer |
978 |
95 |
Classification |
| GSE25458 |
Gene expression in endometrial cancer cells treated with metastin-10 (kp10) |
Endometrial Cancer |
978 |
12 |
Classification |
| GSE25487 |
Expression of SV40 TAg signature in MDAMB231 cells, tumors, and normal human mammary epithelial cells (M98040 and M99005) |
[] |
978 |
21 |
Classification |
| GSE26027 |
Early dynamic transcriptomic changes as predictors of preoperative radiotherapy efficacy in patients with rectal cancer: a feasibility study. |
Rectal Cancer |
978 |
12 |
Classification |
| GSE26309 |
A Transcriptomic Analysis of NET1 (a RhoA GEF Exchange Factor) in AGS Gastric Cancer Cells |
Gastric Cancer |
978 |
12 |
Classification |
| GSE26511 |
Involvement of the TGF-β and β-catenin pathways in pelvic lymph node metastasis in early stage cervical cancer |
Cervical Cancer |
978 |
39 |
Classification |
| GSE26712 |
A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer |
Ovarian Cancer |
978 |
195 |
Classification |
| GSE26834 |
Expression data from MCF-7 cells stimulated by Estrogen or IGF-I |
Breast Cancer |
978 |
17 |
Classification |
| GSE26910 |
Stromal molecular signatures of breast and prostate cancer |
Prostate Cancer |
978 |
24 |
Classification |
| GSE27020 |
Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer. |
[] |
978 |
109 |
Classification |
| GSE27120 |
Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment |
Breast Cancer |
978 |
79 |
Classification |
| GSE27262 |
Gene expression profiling of Non-small cell lung cancer in Taiwan |
Lung Cancer |
978 |
50 |
Classification |
| GSE27431 |
miRNAs in ovarian cancer: A systems approach (MAS5, plier, GCRMA) |
Ovarian Cancer |
978 |
30 |
Classification |
| GSE27489 |
SCREENING STUDY TO IDENTIFY DIAGNOSTIC MARKERS FOR LUNG CANCER IN ENDOBRONCHIAL LINING FLUID |
Lung Cancer |
978 |
30 |
Classification |
| GSE27562 |
Expression data from human PBMCs from breast cancer patients and controls |
Brain Cancer |
978 |
162 |
Classification |
| GSE27651 |
The Anterior Gradient Homolog 3 (AGR3) Gene Is Associated with Differentiation and Survival in Ovarian Cancer |
Ovarian Cancer |
978 |
49 |
Classification |
| GSE27830 |
Expression data from primary breast tumors |
Breast Cancer |
978 |
155 |
Classification |
| GSE27854 |
Overexpression of NUCKS1 in colorectal cancer correlates with recurrence after curative surgery (gene expression analysis) |
Colorectal Cancer |
978 |
115 |
Classification |
| GSE27914 |
Expression data from LNCap cell line treated with COP1 (RFWD2), ETV1, and JUN siRNAs |
Prostate Cancer |
978 |
31 |
Classification |
| GSE28571 |
Gene Copy Number Aberrations are Associated with Survival in Histological Subgroups of Non-Small Cell Lung Cancer (expression data) |
Lung Cancer |
978 |
100 |
Classification |
| GSE28583 |
Differentially expressed genes after treatment with chemotherapy in breast cancer and their correlation with pathologic mid-response (Miller & Payne grade 3) |
Breast Cancer |
978 |
20 |
Classification |
| GSE28645 |
SRC1 gene regulation in endocrine resistant breast cancer cells |
Breast Cancer |
978 |
14 |
Classification |
| GSE28691 |
Characterization of an Oxaliplatin Sensitivity Predictor in a preclinical Murine Model of Colorectal Cancer |
Colorectal Cancer |
978 |
42 |
Classification |
| GSE28694 |
Differentially expressed genes after treatment with chemotherapy in breast cancer and their correlation with pathologic good response (Miller & Payne grades 4 and 5) |
Breast Cancer |
978 |
13 |
Classification |
| GSE28702 |
CRC samples for FOLFOX therapy prediction |
Colorectal Cancer |
978 |
83 |
Classification |
| GSE28826 |
Differentially expressed genes after treatment with chemotherapy in breast cancer and their correlation with pathologic bad response (Miller & Payne grades 1 and 2) |
Breast Cancer |
978 |
28 |
Classification |
| GSE28844 |
Differentially expressed genes after treatment with chemotherapy in breast cancer and their correlation with pathologic response |
Breast Cancer |
978 |
61 |
Classification |
| GSE29013 |
Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non-Small-Cell Lung Cancer Patients |
Lung Cancer |
978 |
55 |
Classification |
| GSE29077 |
Expression data comparing azacitidine and decitabine in non-small cell lung cancer lines |
Lung Cancer |
978 |
28 |
Classification |
| GSE29175 |
Expression data from ovarian cancer cell lines |
Ovarian Cancer |
978 |
38 |
Classification |
| GSE29220 |
Discovery of salivary transcriptomic biomarkers for ovarian cancer |
Ovarian Cancer |
978 |
22 |
Classification |
| GSE29272 |
Affymetrix gene expression array data for cardia and non-cardia gastric cancer samples |
Gastric Cancer |
978 |
268 |
Classification |
| GSE29330 |
Identification of GNG7 as An Epigenetically Silenced Gene in Head and Neck Cancer by Gene Expression Profiling |
Head and Neck Cancer |
978 |
18 |
Classification |
| GSE29431 |
Identifying breast cancer biomarkers |
Breast Cancer |
978 |
66 |
Classification |
| GSE29437 |
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer |
Endometrial Cancer |
978 |
14 |
Classification |
| GSE29561 |
Response prediction to neoadjuvant chemotherapy |
Breast Cancer |
978 |
22 |
Classification |
| GSE29621 |
mRNA and microRNA profile in colon cancer [mRNA data] |
Colon Cancer |
978 |
65 |
Classification |
| GSE29721 |
The landscape of promoter DNA hypomethylation in liver cancer (expression data) |
Liver Cancer |
978 |
20 |
Classification |
| GSE2990 |
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis |
Breast Cancer |
978 |
189 |
Classification |
| GSE30174 |
Molecular-genetic correlates of fatigue in cancer patients receiving localized external beam radiation therapy |
Prostate Cancer |
978 |
80 |
Classification |
| GSE30219 |
"Off-context" gene expression in lung cancer identifies a group of metastatic-prone tumors |
Lung Cancer |
978 |
307 |
Classification |
| GSE30292 |
Establishment of objective criteria for selecting relevant intestinal cell-based models |
[] |
978 |
43 |
Classification |
| GSE30494 |
Expression data in cancer cell lines using Affymetrix GeneChip |
[] |
978 |
12 |
Classification |
| GSE31189 |
Molecular Biomarker Signature for Bladder Cancer Detection |
Bladder Cancer |
978 |
92 |
Classification |
| GSE31192 |
Molecular Signature of Pregnancy Associated Breast Cancer (PABC) |
Breast Cancer |
978 |
33 |
Classification |
| GSE31448 |
Down-regulation of ECRG4, a candidate tumor suppressor gene in human breast cancer |
Breast Cancer |
978 |
357 |
Classification |
| GSE31519 |
A Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer |
Breast Cancer |
978 |
67 |
Classification |
| GSE31546 |
UMCCC Primary Lung Cancer Specimens |
Lung Cancer |
978 |
17 |
Classification |
| GSE31547 |
MSKCC-A Primary Lung Cancer Specimens |
Lung Cancer |
978 |
50 |
Classification |
| GSE31595 |
Gene Expression Profiles in Stage II and III Colon Cancer. Application of a 128-gene signature |
Colorectal Cancer |
978 |
37 |
Classification |
| GSE31625 |
Gene Expression Patterns that Predict Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer Cell Lines and Human Lung Tumors |
Lung Cancer |
978 |
48 |
Classification |
| GSE3167 |
Classification of carcinoma in situ lesions in human bladder cancer |
Bladder Cancer |
978 |
60 |
Classification |
| GSE31684 |
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer |
Bladder Cancer |
978 |
93 |
Classification |
| GSE3202 |
MK886 treatment of H720 non-small cell lung cancer cell line |
Lung Cancer |
978 |
23 |
Classification |
| GSE32072 |
Expression data from breast cancer FNA and surgical specimens from patients |
Breast Cancer |
978 |
50 |
Classification |
| GSE32175 |
Development of Transcriptomic Biomarker Signature in Human Saliva to Detect Lung Cancer |
Lung Cancer |
978 |
20 |
Classification |
| GSE32269 |
Expression data for primary localized prostate cancer versus castration-resistant bone metastatic prostate cancer |
Prostate Cancer |
906 |
55 |
Classification |
| GSE32323 |
Screening for Epigenetically Masked Genes in Colorectal Cancer using 5-aza-2’-deoxycytidine treatment, Microarray and Gene Expression Profile |
Colorectal Cancer |
978 |
44 |
Classification |
| GSE32474 |
Comparison between cell lines from 9 different cancer tissue (NCI-60) (Affymetrix U133 Plus 2.0) |
Central Nervous System |
978 |
174 |
Classification |
| GSE32496 |
GENOME-WIDE CpG ISLAND METHYLATION ANALYSIS IN NON-SMALL CELL LUNG CANCER PATIENTS [Affymetrix expression data] |
Lung Cancer |
978 |
18 |
Classification |
| GSE32518 |
Expression data from paired matched breast cancer Fine needle aspiration (FNA) or Core needle biopsies (CBX) |
Breast Cancer |
978 |
74 |
Classification |
| GSE32526 |
Expression data from breast cancer tumor-initiating cells |
Breast Cancer |
978 |
12 |
Classification |
| GSE32646 |
GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer |
Breast Cancer |
978 |
115 |
Classification |
| GSE32676 |
Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer [mRNA] |
Pancreatic Cancer |
978 |
32 |
Classification |
| GSE32701 |
Individual aiEMT in surgical samples of esophageal cancer patients |
Esophageal Cancer |
978 |
40 |
Classification |
| GSE32967 |
Modeling lethal prostate cancer variant with small cell carcinoma features |
Prostate Cancer |
978 |
22 |
Classification |
| GSE33112 |
Gene expression in colon cancer stem cells (CSC) cultures identified by Wnt signaling levels |
Colon Cancer |
978 |
12 |
Classification |
| GSE33116 |
Breast cancer and liver tissue biopsies used to develop and validate an index for liver contamination in metastatic breast cancer |
Breast Cancer |
978 |
203 |
Classification |
| GSE33455 |
Expression data from docetaxel-resistant prostate cancer cell lines |
Prostate Cancer |
978 |
12 |
Classification |
| GSE33532 |
Intratumor heterogeneity of gene expression profiles in early stage non-small cell lung cancer (NSCLC) |
Lung Cancer |
951 |
100 |
Classification |
| GSE33658 |
A phase II neoadjuvant trial of anastrozole (A), fulvestrant (F) and gefitinib (I - iressa) in patients with newly diagnosed estrogen receptor positive breast cancer |
Breast Cancer |
978 |
22 |
Classification |
| GSE33874 |
Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer |
Ovarian Cancer |
978 |
20 |
Classification |
| GSE34042 |
Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer |
Prostate Cancer |
978 |
12 |
Classification |
| GSE34111 |
Gene expression in skeletal muscle of cancer patients before and after potentially curative surgery |
[] |
978 |
30 |
Classification |
| GSE34112 |
Effect of NO-sulindac treatment on hypoxic prostate cancer cells |
Prostate Cancer |
978 |
16 |
Classification |
| GSE34405 |
Differential gene expression in ovarian cancer cell lines treated with vehicle or norepinephrine |
Ovarian Cancer |
978 |
15 |
Classification |
| GSE35006 |
Profiling of p53-responsive genes in human breast cancer cells harboring endogenous ts-p53 E285K |
Breast Cancer |
978 |
18 |
Classification |
| GSE35144 |
Molecular Evaluation of Patient-Derived Colorectal Cancer Explants as a Pre-clinical Mouse Model of Colorectal Cancer |
Colorectal Cancer |
978 |
64 |
Classification |
| GSE35428 |
Transcriptional profiling of clinically relevant SERMs and SERM/estradiol complexes in a cellular model of breast cancer |
Breast Cancer |
978 |
106 |
Classification |
| GSE35452 |
Prediction of sensitivity of rectal cancer cells in response to preoperative chemoradiotherapy by DNA microarray analysis of gene expression profiles. |
Rectal Cancer |
978 |
46 |
Classification |
| GSE35570 |
Gene signature of the post-Chernobyl papillary thyroid cancer |
Thyroid Cancer |
978 |
116 |
Classification |
| GSE35603 |
Network Biology of Tumor Stem-like Cells Identified a Regulatory Role of CBX5 in Lung Cancer |
[] |
978 |
78 |
Classification |
| GSE35640 |
Identification of a predictive gene signature to recMAGE A3 antigen-specific cancer immunotherapy in metastatic melanoma and non-small-cell lung cancer |
Melanoma |
978 |
65 |
Classification |
| GSE35809 |
Gastric Cancer Subtyping (Australian Patient Cohort) |
Gastric Cancer |
978 |
70 |
Classification |
| GSE35896 |
Gene expression data from 62 colorectal cancers |
Colorectal Cancer |
978 |
62 |
Classification |
| GSE35925 |
Calcitriol supplementation effects on Ki67 expression and transcriptional profile of breast cancer specimens from post-menopausal patients |
Breast Cancer |
978 |
30 |
Classification |
| GSE36076 |
A combined strategy of global gene expression analysis and multiplex PCR established a 13-member gene signature for the diagnosis of human hepatocellular carcinoma. |
'Hepatocellular carcinoma' |
977 |
26 |
Classification |
| GSE36176 |
Gene expression arrays on lung cancer cells exposed to Notch inhibitor |
Lung Cancer |
978 |
32 |
Classification |
| GSE3629 |
Molecular Marker for predicting development of cancer in ulcerative colitis |
[] |
978 |
121 |
Classification |
| GSE36389 |
Identification of the differences between expression patterns of kinin-dependent genes in endometrial cancer |
Endometrial Cancer |
978 |
20 |
Classification |
| GSE36765 |
Gene expression profiling of CD4+ T cells infiltrating human breast cancer (Discovery Set) |
Breast Cancer |
978 |
34 |
Classification |
| GSE36769 |
CD4+ TIL in human breast cancer |
Breast Cancer |
978 |
60 |
Classification |
| GSE3678 |
PTC versus paired normal thyroid tissue |
[] |
978 |
14 |
Classification |
| GSE37185 |
miR-1204 promotes tumor development in breast and ovarian cancer cell lines |
Breast Cancer |
978 |
14 |
Classification |
| GSE37290 |
Expression Data from HNF1b-knockdown RMG2-ovarian cancer cells |
Ovarian Cancer |
978 |
20 |
Classification |
| GSE3744 |
Human breast tumor expression |
[] |
978 |
47 |
Classification |
| GSE37645 |
The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models |
Pancreatic Cancer |
978 |
18 |
Classification |
| GSE37745 |
Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis and tissue microarray validation |
Lung Cancer |
978 |
196 |
Classification |
| GSE37946 |
HER2-enriched tumor initiating cell (HTIC) genomic predictor of response following neoadjuvant trastuzumab-based chemotherapy in HER2+ breast cancer |
Breast Cancer |
978 |
50 |
Classification |
| GSE37964 |
Expression data from three human DLD-1-derived colon cancer cell lines |
Colon Cancer |
978 |
44 |
Classification |
| GSE38129 |
A pilot study of integrative genomics analysis of genes with biallelic loss and its relation to the expression of mRNA and micro-RNA in esophageal squamous cell cancer |
[] |
978 |
60 |
Classification |
| GSE38666 |
Molecular Profiling provides evidence of the existence of two functionally distinct classes of ovarian cancer stroma |
Ovarian Cancer |
978 |
45 |
Classification |
| GSE38832 |
NFAT transcriptional activity is associated with metastatic capacity in colon cancer |
Colorectal Cancer |
978 |
122 |
Classification |
| GSE39204 |
Gene-expression profiles of ascites-cytology-positive ovarian cancer |
Ovarian Cancer |
978 |
64 |
Classification |
| GSE39354 |
Expression profiling of human prostate VCaP and LNCaP cancer cells after silencing ERG or ETV1, respectively |
Prostate Cancer |
978 |
24 |
Classification |
| GSE39452 |
Expression data of EZH2-dependent genes in prostate cancer cell lines |
Prostate Cancer |
978 |
12 |
Classification |
| GSE39582 |
Gene expression Classification of Colon Cancer defines six molecular subtypes with distinct clinical, molecular and survival characteristics [Expression] |
Colon Cancer |
978 |
585 |
Classification |
| GSE39923 |
The COLCATS study: Identification of an anti-apoptotic druggable target signature for the treatment of colorectal cancer |
Colorectal Cancer |
978 |
101 |
Classification |
| GSE40367 |
Gene expression analysis of liver and colon cancer primary tumors and metastasis |
Colon Cancer |
978 |
61 |
Classification |
| GSE40595 |
A cancer associated fibroblasts (CAFs) specific gene signature in high grade serous ovarian cancer |
Ovarian Cancer |
978 |
77 |
Classification |
| GSE40654 |
Does Type of Dietary Fat Matter? Prostate Cancer Xenograft Progression in a SCID Mouse Model with Varying Dietary Fat Sources |
Prostate Cancer |
978 |
24 |
Classification |
| GSE40968 |
The effect of ACSL4 expression on overall gene expression in breast cancer cell lines |
Breast Cancer |
978 |
18 |
Classification |
| GSE41035 |
FGFR3-shRNA induced transcriptional changes in RT112 bladder cancer cells |
Bladder Cancer |
978 |
24 |
Classification |
| GSE4107 |
Expression profiling in early onset colorectal cancer |
Colorectal Cancer |
978 |
22 |
Classification |
| GSE4115 |
Airway Epithelial Gene Expression Diagnostic for the Evaluation of Smokers with Suspect Lung Cancer |
Lung Cancer |
978 |
192 |
Classification |
| GSE41258 |
Expression data from colorectal cancer patients |
Colorectal Cancer |
978 |
390 |
Classification |
| GSE4127 |
Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database |
Lung Cancer |
978 |
29 |
Classification |
| GSE41445 |
Basal gene expression data of 21 cell lines (18 cancer and 3 non-tumorigenic) |
[] |
978 |
63 |
Classification |
| GSE41559 |
Expression data by telomere elongation in vivo (xenograft) |
Prostate Cancer |
978 |
16 |
Classification |
| GSE41568 |
A Molecular Profile of Colorectal Cancer to Guide Therapy [PDCCEs] |
Colorectal Cancer |
978 |
133 |
Classification |
| GSE41627 |
DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs |
Breast Cancer |
978 |
12 |
Classification |
| GSE4183 |
Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature |
[] |
978 |
53 |
Classification |
| GSE41998 |
Biomarker analysis of neoadjuvant Doxorubicin/Cyclophosphamide followed by Ixabepilone or Paclitaxel in early-stage breast cancer |
Breast Cancer |
978 |
279 |
Classification |
| GSE42404 |
The side population of human pancreatic cancer expresses cancer stem cell-associated genes |
Pancreatic Cancer |
978 |
22 |
Classification |
| GSE42568 |
Breast Cancer Gene Expression Analysis |
Breast Cancer |
978 |
121 |
Classification |
| GSE42822 |
Expression data from breast cancer FNA biopsies from patients ( (USO samples) |
Breast Cancer |
978 |
91 |
Classification |
| GSE43358 |
Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology |
Breast Cancer |
978 |
57 |
Classification |
| GSE43365 |
Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer |
Breast Cancer |
978 |
111 |
Classification |
| GSE43502 |
Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple Negative Breast Cancer |
Breast Cancer |
978 |
25 |
Classification |
| GSE43580 |
SBV - Gene Expression Profiles of Lung Cancer Tumors - Adenocarcinomas and Squamous Cell Carcinomas |
Lung Cancer |
978 |
150 |
Classification |
| GSE44104 |
COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer. |
Ovarian Cancer |
978 |
60 |
Classification |
| GSE44408 |
Transcriptomic survey of lymph node-positive vs. - negative ductal breast cancer |
Breast Cancer |
978 |
44 |
Classification |
| GSE44861 |
Affymetrix expression data from colon cancer patient tissues |
Colon Cancer |
978 |
111 |
Classification |
| GSE4526 |
Gene expression signature and the prediction of recurrence in stage III colorectal cancer by DNA microarray |
Colorectal Cancer |
978 |
36 |
Classification |
| GSE4536 |
Tumor stem cells more closely mirror the phenotype and genotype of primary human tumors than do cancer cell lines |
glioblastoma |
978 |
101 |
Classification |
| GSE4554 |
Gene expression signature of colorectal cancer with microsatellite instability. |
Colorectal Cancer |
978 |
84 |
Classification |
| GSE45626 |
Expression data from IGF-1R targeting in 33 NCI-H526 SCLC (small-cell lung cancer) xenografts |
Lung Cancer |
978 |
33 |
Classification |
| GSE45757 |
Expression Data from 22 human pancreatic cancer cell lines grown in triplicates +/- MEK inhibitor CI-1040 |
Pancreatic Cancer |
978 |
141 |
Classification |
| GSE45765 |
Expression Data from pancreatic cancer cell lines and orthotopic tumors grown with and without MEK inhibitor |
Pancreatic Cancer |
978 |
165 |
Classification |
| GSE46106 |
Patient-derived Human Breast Cancer Xenografts |
Breast Cancer |
978 |
44 |
Classification |
| GSE46222 |
Molecular signaling distinguishes early from late recurrences in ER positive breast cancer |
Breast Cancer |
978 |
49 |
Classification |
| GSE46602 |
Expression data from prostate cancer and benign prostate glands |
Prostate Cancer |
978 |
50 |
Classification |
| GSE46928 |
Downstream Signaling Modeling of Cancer Signaling Pathways Enables Systematic Drug Respositioning for Subtypes of Breast Cancer Metastases |
Breast Cancer |
978 |
52 |
Classification |
| GSE48390 |
Concurrent Gene Signatures for Han Chinese Breast Cancers [Affymetrix] |
Breast Cancer |
978 |
81 |
Classification |
| GSE48433 |
Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
[] |
978 |
823 |
Classification |
| GSE48984 |
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple negative breast tumor therapeutic target. |
Breast Cancer |
978 |
26 |
Classification |
| GSE49349 |
CHIP knockdown effect on breast cancer cell line |
Breast Cancer |
978 |
20 |
Classification |
| GSE49515 |
Expression profiling of PBMC from patients with hepatocellular carcinoma |
'Hepatocellular carcinoma' |
978 |
26 |
Classification |
| GSE49588 |
Expression data from pancreatic stellate cells and cancer cell line MiaPaca2 |
[] |
978 |
28 |
Classification |
| GSE50081 |
Validation of a histology-independent prognostic gene signature for early stage, non-small cell lung cancer including stage IA patients |
Lung Cancer |
978 |
181 |
Classification |
| GSE50567 |
BRCA1-related gene signature in breast cancer: the role of ER status and molecular type |
Breast Cancer |
978 |
41 |
Classification |
| GSE50705 |
Xenoestrogen Dose-dependent Transcriptomal Changes in MCF-7 Human Breast Cancer Cells |
Breast Cancer |
978 |
351 |
Classification |
| GSE50811 |
Breast cancer cell lines treated with eribulin and paclitaxel |
Breast Cancer |
978 |
241 |
Classification |
| GSE50830 |
Endometrial cancer cell lines treated with eribulin and paclitaxel |
Ovarian Cancer |
978 |
168 |
Classification |
| GSE50831 |
Ovarian cancer cell lines treated with eribulin and paclitaxel |
Ovarian Cancer |
978 |
189 |
Classification |
| GSE50832 |
Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells |
Breast Cancer |
978 |
598 |
Classification |
| GSE50948 |
Expression Data from transNOAH breast cancer trial |
Breast Cancer |
978 |
156 |
Classification |
| GSE51021 |
DKK1 expression is down-regulated in the lymph node pre-metastatic niche in esophageal cancer |
Esophageal Cancer |
978 |
28 |
Classification |
| GSE51242 |
A Molecular Profile of Colorectal Cancer to Guide Therapy [HMEC] |
Colorectal Cancer |
978 |
20 |
Classification |
| GSE51373 |
Gene expression data from high grade serous ovarian cancer |
Ovarian Cancer |
978 |
28 |
Classification |
| GSE51450 |
Gene expression profiling of FFPE breast cancer samples [Affymetrix platform] |
Breast Cancer |
978 |
12 |
Classification |
| GSE51524 |
LNCaP prostate cancer cell lines overexpressing wild-type or GARRPR-mutant Bag-1L |
Prostate Cancer |
978 |
18 |
Classification |
| GSE52171 |
Novel Immunotherapy-Induced Tertiary Lymphoid Aggregates Accumulate as Intratumoral Nodal Structures of Immune Regulation in Pancreatic Cancer |
Melanoma |
978 |
20 |
Classification |
| GSE52327 |
Expression data of ALDH+ breast cancer cells |
Breast Cancer |
978 |
16 |
Classification |
| GSE52712 |
Flexible multiplatform RNA profiling at the single cell level applied to enriched cancer initiating cells: Affymetrix array data |
[] |
978 |
20 |
Classification |
| GSE53012 |
Expression data from three human cancer cell lines (PC-3, SK-OV-3, WM793B) exposed to experimental cycling and chronic hypoxa in vitro |
Melanoma |
978 |
27 |
Classification |
| GSE53059 |
Human Subperitoneal Fibroblasts and Cancer Cell Interaction Creates Microenvironment Enhancing Tumor Progression and Metastasis |
Colon Cancer |
978 |
12 |
Classification |
| GSE5327 |
Breast cancer relapse free survival and lung metastasis free survival |
Breast Cancer |
978 |
58 |
Classification |
| GSE53668 |
Identification and Validation of Genes with Expression Patterns Inverse to Multiple Metastasis Suppressor Genes in Breast Cancer Cell Lines |
Breast Cancer |
978 |
77 |
Classification |
| GSE54002 |
Gene expression profiling of LCM captured breast cancer cells |
Breast Cancer |
978 |
433 |
Classification |
| GSE54129 |
Global gene expression analysis of gastric cancer by oligonucleotide microarrays |
Gastric Cancer |
978 |
132 |
Classification |
| GSE54323 |
Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer |
Breast Cancer |
978 |
29 |
Classification |
| GSE54388 |
Identification of differentially expressed transcription factors in ovarian cancer |
Ovarian Cancer |
978 |
22 |
Classification |
| GSE54495 |
Field of Cancerization in Peripheral Airway Epithelium: Gene Expresssion |
Lung Cancer |
978 |
30 |
Classification |
| GSE5460 |
Predicting Features of Breast Cancer with Gene Expression Patterns |
Breast Cancer |
978 |
129 |
Classification |
| GSE55945 |
Gene Expression Profiling of Prostate Benign and Malignant Tissue |
[] |
978 |
21 |
Classification |
| GSE56026 |
Gene expression in human endometrial cancer tissues and serous papillary endometrial cancer cell line, SPAC-1L, treated by STAT1-siRNA and/or IFN-gamma |
Endometrial Cancer |
978 |
75 |
Classification |
| GSE56352 |
Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer |
Prostate Cancer |
978 |
24 |
Classification |
| GSE56465 |
Comparison of haploid and diploid clones of KBM7 cancer cell line |
[] |
978 |
38 |
Classification |
| GSE5787 |
Survey of Intra- and Inter-Tumour Heterogeneity of Gene Expression in Cervical Cancer |
Cervical Cancer |
978 |
33 |
Classification |
| GSE57968 |
Methylome remodeling in regional breast cancer metastasis [expression] |
Breast Cancer |
978 |
72 |
Classification |
| GSE5816 |
A Genome-wide Screen for Hypermethylated Genes in Lung Cancer |
Breast Cancer |
978 |
42 |
Classification |
| GSE5847 |
Tumor and stroma from breast by LCM |
Breast Cancer |
978 |
95 |
Classification |
| GSE58792 |
Effects of soy supplementation on gene expression in breast cancer |
Breast Cancer |
978 |
51 |
Classification |
| GSE58812 |
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response |
Breast Cancer |
978 |
107 |
Classification |
| GSE58984 |
Gene profiling of HER2 breast cancer patients treated with adjuvant trastuzumab |
Breast Cancer |
978 |
94 |
Classification |
| GSE59196 |
Frequent Loss-of-Function Mutations in MLK4 Suppresses Signaling in the JNK-cJUN-p21/p15 Pathway to Promote Growth of Colon Cancer Cells |
Colorectal Cancer |
978 |
24 |
Classification |
| GSE59732 |
Gene expression profiling in response to radiation treatment in breast cancer [cell lines] |
Breast Cancer |
978 |
96 |
Classification |
| GSE6044 |
Genetic programming and gene expression profiling for molecular discrimination and characterization of lung cancers |
Lung Cancer |
586 |
47 |
Classification |
| GSE60542 |
Revisiting the transcriptional analysis of primary tumors and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer |
Head and Neck Cancer |
978 |
92 |
Classification |
| GSE60697 |
Expression data from 20 human colon cancer |
Colorectal Cancer |
978 |
20 |
Classification |
| GSE61304 |
Novel bio-marker discovery for stratification and prognosis of breast cancer patients |
Breast Cancer |
978 |
62 |
Classification |
| GSE61548 |
Expression data in NK150460 treated breast cancer cell lines |
Breast Cancer |
586 |
20 |
Classification |
| GSE61942 |
The gene expression profile of renal cell carcinoma cell line (786-O) versus prostate cancer cell line (PC3) in co-culture with primary murine muscle progenitor cells |
Prostate Cancer |
978 |
12 |
Classification |
| GSE62080 |
Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan |
Colorectal Cancer |
978 |
21 |
Classification |
| GSE62932 |
Comparison of Nanostring nCounter data on FFPE colon cancer samples and Affymetrix microarray data on matched frozen tissues |
Colorectal Cancer |
978 |
68 |
Classification |
| GSE63252 |
Induction of ER stress in HCT116 colon cancer cells |
Colon Cancer |
978 |
27 |
Classification |
| GSE63471 |
Implementing whole genome array for clinical use in academic centers: A randomized trial comparing neoadjuvant standard chemotherapy to genomic-driven chemotherapy in operable breast cancer (REMAGUS04 trial) |
Breast Cancer |
978 |
142 |
Classification |
| GSE63514 |
Gene expression analysis of cervical cancer progression |
Cervical Cancer |
978 |
128 |
Classification |
| GSE63678 |
Expression data from Vulvar, Cervical, Endometrial Carcinoma tissue |
Vulvar Cancer |
978 |
35 |
Classification |
| GSE63885 |
Gene expression profiling in ovarian cancer |
Ovarian Cancer |
978 |
101 |
Classification |
| GSE64256 |
Prognostic significance of overexpression of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer [gene expression] |
Colorectal Cancer |
978 |
125 |
Classification |
| GSE64857 |
Gene expression data from patients with colorectal cancer |
Colorectal Cancer |
978 |
81 |
Classification |
| GSE64951 |
Discovered salivary transcriptomic biomarkers for the detection of gastric cancer |
Gastric Cancer |
978 |
94 |
Classification |
| GSE65194 |
Expression profiling of breast cancer samples from Institut Curie (Maire cohort) --Affy CDF |
Breast Cancer |
978 |
178 |
Classification |
| GSE66161 |
Intermittent energy restriction in overweight women at increased risk of breast cancer |
Breast Cancer |
978 |
74 |
Classification |
| GSE66162 |
Energy restriction in women at increased risk of breast cancer |
Breast Cancer |
978 |
150 |
Classification |
| GSE66229 |
Molecular analysis of gastric cancer identifies discrete subtypes associated with distinct clinical characteristics and survival outcomes: the ACRG (Asian Cancer Research Group) study |
Gastric Cancer |
978 |
400 |
Classification |
| GSE66270 |
Genome-wide analysis of gene expression patterns in human kidney cancer [patients without metastasis] |
Kidney Cancer |
978 |
28 |
Classification |
| GSE66271 |
Genome-wide analysis of gene expression patterns in human kidney cancer [patients with metastasis] |
Kidney Cancer |
978 |
26 |
Classification |
| GSE66272 |
Genome-wide analysis of gene expression patterns in human kidney cancer |
Kidney Cancer |
978 |
54 |
Classification |
| GSE66305 |
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with chemotherapy plus trastuzumab and lapatinib as neoadjuvant therapy for HER2-positive breast cancer [expression] |
Breast Cancer |
978 |
88 |
Classification |
| GSE66667 |
Tumorgrafts as in vivo surrogates for women with ovarian cancer. |
Ovarian Cancer |
978 |
36 |
Classification |
| GSE67916 |
Gene expression analysis in tamoxifen resistant ER+ breast cancer cell lines |
Breast Cancer |
978 |
18 |
Classification |
| GSE68468 |
caArray_notte-00422: Molecular Dissection of Colon Cancer |
Colon Cancer |
978 |
390 |
Classification |
| GSE69223 |
Genome-wide analysis of gene expression patterns in human prostate cancer (PCa) |
Prostate Cancer |
978 |
30 |
Classification |
| GSE69330 |
Identification of TRIM24-dependent gene expression programs in prostate cancer cells. |
Prostate Cancer |
978 |
18 |
Classification |
| GSE69428 |
Transformation of Human Fallopian Tube Stem Cells and high grade serous ovarian cancer |
Ovarian Cancer |
970 |
29 |
Classification |
| GSE6956 |
Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men |
Prostate Cancer |
978 |
89 |
Classification |
| GSE69657 |
Identification of HOXB8 and K LK11 expression levels as potential biomarkers to predict the effects of FOLFOX4 chemotherapy |
Colorectal Cancer |
978 |
30 |
Classification |
| GSE70915 |
Inhibition of Akt Signaling in PIK3R2 Overexpressing Colon Cancer Stem Cells Reduces Tumor Growth due Apoptosis and Decreased Mucin Production |
Colon Cancer |
978 |
12 |
Classification |
| GSE71222 |
Prognostic significance of overexpression of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer [152 samples] |
Colorectal Cancer |
978 |
152 |
Classification |
| GSE71258 |
Identification of genes associated with breast cancer micrometastatic disease in bone marrow disseminated tumor cells (DTCs) |
Breast Cancer |
978 |
128 |
Classification |
| GSE71363 |
5-aza treatment of breast cancer and non-tumorigenic breast cells |
Breast Cancer |
978 |
18 |
Classification |
| GSE72968 |
Molecular subtypes of metastatic colorectal cancer are predictive of patient response to chemo and targeted therapies (part 1) |
Colorectal Cancer |
978 |
68 |
Classification |
| GSE72969 |
Molecular subtypes of metastatic colorectal cancer are predictive of patient response to chemo and targeted therapies (part 2) |
Colorectal Cancer |
978 |
56 |
Classification |
| GSE72970 |
Molecular subtypes of metastatic colorectal cancer are predictive of patient response to chemo and targeted therapies |
Colorectal Cancer |
978 |
124 |
Classification |
| GSE73168 |
Gene expression profile of tumor cells from primary tumors, ascites and metastases of high and low grade serous ovarian cancer patients |
Ovarian Cancer |
978 |
24 |
Classification |
| GSE74391 |
High CDK6 protects cells from fulvestrant-mediated apoptosis and is a predictor of resistance to fulvestrant in estrogen receptor-positive metastatic breast cancer |
Breast Cancer |
978 |
26 |
Classification |
| GSE74530 |
Expression data from tumors and adjacent normal tissue from clinical oral cancer patients |
Oral Cancer |
978 |
12 |
Classification |
| GSE74572 |
Effect of APE1 and its acetylation on gene expression profile of lung cancer cells |
Lung Cancer |
978 |
21 |
Classification |
| GSE74608 |
A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response [BT20 & HCC1806] |
Breast Cancer |
978 |
12 |
Classification |
| GSE7515 |
Gene expression data from cancer mammospheres and bulk tumors |
Breast Cancer |
978 |
26 |
Classification |
| GSE75316 |
Expression data for 59 primary tumors from patients with colorectal cancer |
Colorectal Cancer |
978 |
59 |
Classification |
| GSE76124 |
Comprehensive genomic analysis identify novel subtypes and targets of triple-negative breast cancer (198 TNBC tumors) |
Breast Cancer |
978 |
198 |
Classification |
| GSE76274 |
Comprehensive genomic analysis identify novel subtypes and targets of triple-negative breast cancer (67 not triple-negative tumors) |
Breast Cancer |
978 |
67 |
Classification |
| GSE76275 |
Comprehensive genomic analysis identify novel subtypes and targets of triple-negative breast cancer |
Breast Cancer |
978 |
265 |
Classification |
| GSE76675 |
MCT1 modulates cancer cell pyruvate export and growth of tumors that co-express MCT1 and MCT4 |
Breast Cancer |
978 |
24 |
Classification |
| GSE7670 |
Expression data from Lung cancer |
Lung Cancer |
978 |
66 |
Classification |
| GSE77803 |
Retrospective and prospective validation of a 33-gene signature to predict recurrence of lung cancer after surgery. |
Lung Cancer |
978 |
156 |
Classification |
| GSE78753 |
A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response |
Breast Cancer |
978 |
18 |
Classification |
| GSE78916 |
Insulin receptor substrate adaptor proteins mediate prognostic gene expression profiles in breast cancer |
Breast Cancer |
978 |
48 |
Classification |
| GSE79460 |
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype [adenomas] |
Colorectal Cancer |
978 |
16 |
Classification |
| GSE79461 |
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype [organoids] |
Colorectal Cancer |
978 |
20 |
Classification |
| GSE79462 |
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype |
Colorectal Cancer |
978 |
36 |
Classification |
| GSE79973 |
Expression data from gastric cancer and paried normal tissues |
Gastric Cancer |
978 |
20 |
Classification |
| GSE80077 |
Preoperative short-term hormone therapy for hormone receptor positive breast cancer |
Breast Cancer |
978 |
60 |
Classification |
| GSE81612 |
Active estrogen receptor-alpha signaling in ovarian cancer |
Ovarian Cancer |
978 |
56 |
Classification |
| GSE82171 |
Expression data from primary breast tumors |
Breast Cancer |
978 |
20 |
Classification |
| GSE82172 |
Expression data from primary breast tumors, M0 patients |
Breast Cancer |
978 |
152 |
Classification |
| GSE82208 |
Gene expression markers differentiating between malignant and benign follicular thyroid tumors |
Thyroid Cancer |
978 |
52 |
Classification |
| GSE82298 |
Effects of NOTCH3 signalling on gene expression in breast cancer cells |
Breast Cancer |
978 |
26 |
Classification |
| GSE83120 |
Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs [SPR1108] |
[] |
978 |
12 |
Classification |
| GSE83122 |
Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs |
[] |
978 |
18 |
Classification |
| GSE83530 |
A Window of Opportunity Study of Valproic Acid in Breast Cancer Testing a Gene Expression Biomarker |
Breast Cancer |
978 |
55 |
Classification |
| GSE83937 |
Identification of three subtypes of triple negative breast cancer with potential therapeutic implications |
Breast Cancer |
978 |
131 |
Classification |
| GSE8401 |
Gene Signature for Aggression of Melanoma Metastases - Melanoma Metastasis |
Melanoma |
978 |
83 |
Classification |
| GSE84713 |
Gene expression data from head and neck cancer patient derived xenografts |
Head and Neck Cancer |
978 |
28 |
Classification |
| GSE85043 |
UMCU colon cancer - Biopsies Of Surgical Specimens (BOSS) |
Colon Cancer |
978 |
29 |
Classification |
| GSE85570 |
Inefficient DNA-DSB repair via the homologous recombination pathway in prostate cancer patients with late radiation toxicity |
Prostate Cancer |
978 |
440 |
Classification |
| GSE8894 |
Prediction of Recurrence-Free Survival in Postoperative NSCLC Patients�a Useful Prospective Clinical Practice |
Lung Cancer |
978 |
138 |
Classification |
| GSE8977 |
Bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis |
Breast Cancer |
978 |
22 |
Classification |
| GSE89932 |
Identification of genes that are modulated by BET inhibitors in cancer cells to identify robust pharmacodynamic marker for monitoring target engagement of BET family bromodomain inhibitors in tumors and surrogate tissue |
[] |
978 |
36 |
Classification |
| GSE90521 |
The footprint of the aging stroma in older breast cancer patients. |
Breast Cancer |
978 |
17 |
Classification |
| GSE9195 |
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen |
Breast Cancer |
978 |
77 |
Classification |
| GSE92921 |
Prognostic Model for Stage II/III Colon Cancer Based on Gene Expression Subtypes and KRAS Mutation Status |
Colon Cancer |
978 |
59 |
Classification |
| GSE9350 |
Transcriptome analysis of pancreatic cancer cell line that differ in metastatic potential |
Pancreatic Cancer |
978 |
12 |
Classification |
| GSE95700 |
Molecular subtyping of Triple negative Breast Cancer from Taiwanese |
Breast Cancer |
978 |
57 |
Classification |
| GSE9574 |
Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients |
Breast Cancer |
978 |
29 |
Classification |
| GSE9750 |
Identification of gene expression profiles in cervical cancer |
Cervical Cancer |
978 |
66 |
Classification |
| GSE97549 |
Global microarray analysis of ONECUT2 transcription factor overexpression in human prostate cancer cells |
Prostate Cancer |
978 |
18 |
Classification |
| GSE98265 |
Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis |
Breast Cancer |
978 |
27 |
Classification |
| GSE99213 |
Expression data from SW1990, HCT-116 and Hep3B cancer cell lines |
[] |
978 |
16 |
Classification |
| GSE9936 |
Expression data from human breast cancer cells (MCF-7) coexpressing ERalpha and Erbeta, treated with phytoestrogens |
Breast Cancer |
978 |
105 |
Classification |
| GSE994 |
Effects of cigarette smoke on the human airway epithelial cell transcriptome (Lung Cancer) |
[] |
978 |
75 |
Classification |
| GSE9971 |
CYP3A5 Gene Expression is Associated with Early Recurrence of Non-small Cell Lung Cancer |
Lung Cancer |
978 |
27 |
Classification |
| GSE99861 |
The effect of EDI3 inhibition in MCF7 breast cancer cells |
Breast Cancer |
978 |
16 |
Classification |